SCHEMBL16257554

SCHEMBL16257554

COc1nc(Nc2ccc(Cl)c(Cl)c2)c(C)c(C(=O)N2CCC(NC3CCOCC3)CC2)n1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 2/20 0.63
CCR5 P51681 1/20 0.63
EPHA2 P29317 2/20 0.41
KDR P35968 2/20 0.41
EPHB4 P54760 1/20 0.41
LRRK2 Q5S007 4/20 0.39
EGFR P00533 2/20 0.38
ERBB2 P04626 1/20 0.38
LCK P06239 3/20 0.38
PTK6 Q13882 3/20 0.38
AURKB Q96GD4 2/20 0.38
OPRK1 P41145 3/20 0.37
AXL P30530 1/20 0.37
TYRO3 Q06418 1/20 0.37
MERTK Q12866 1/20 0.37
EPHX2 P34913 1/20 0.36
RET P07949 1/20 0.36
ROS1 P08922 1/20 0.36
FLT3 P36888 1/20 0.36
EML4 Q9HC35 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16257572 0.89 CCR2 (0.69) CCR2CCR5EPHA2KDREPHB4
SCHEMBL16257523 0.89 CCR2 (0.80) CCR2CCR5EPHA2KDREPHB4
SCHEMBL16257522 0.89 CCR2 (0.80) CCR2CCR5EPHA2KDREPHB4
SCHEMBL16257561 0.86 CCR2 (0.78) CCR2CCR5EPHA2KDREPHB4
SCHEMBL16257557 0.86 CCR2 (0.60) CCR2CCR5EPHA2KDREPHB4
SCHEMBL16257525 0.84 CCR2 (0.48) CCR2CCR5EGFROPRK1EPHX2
SCHEMBL15033674 0.81 CCR2 (0.53) CCR2CCR5EPHA2KDREPHB4
SCHEMBL15033672 0.81 CCR2 (0.53) CCR2CCR5EPHA2KDREPHB4
SCHEMBL12179993 0.79 CCR2 (0.79) CCR2CCR5LRRK2
SCHEMBL12180006 0.79 CCR2 (0.79) CCR2CCR5LRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8946218-B2 CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-02-03 US disclosed
EP-2569295-B1 NEW CCR2 RECEPTOR ANTAGONISTS, METHOD FOR PRODUCING THE SAME, AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed